-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(Health Times reporter Xu Wei Zhanghe)
" Send pathology glass foreign consultation, a basic cost of 1400 dollars or more, converted into RMB may be more than 10,000 yuan. In China, even if the subject of the top expert consultation, it is 1000 yuan," said Professor Lin Yu of sun yat-sen University Cancer Hospital, who is the chief of the oncology branch of the Chinese Medical Association, in an interview with reporters at the 2019 China Cancer Conference. In fact, the current level of Chinese cancer treatment has been in line with international standards, foreign medical treatment programs are not necessarily more efficient than domestic, domestic may be more appropriate.
the Chinese Medical Association Cancer Branch-designate, Sun Yat-sen University Cancer Hospital Professor Lin Yu
to proton radiotherapy to treat prostate cancer as an example, Shanghai has introduced equipment for early prostate cancer patients targeted and efficient treatment, a few years ago china is not this condition, but now up, the results proved to be very good, all over the country are also beginning to introduce new technology.
"Many patients will think that the United States and Japan have been using proton radiotherapy for more than a decade, certainly more reliable, in fact, the treatment effect is the same." Lin said.
Linton, the current immunotherapy effect is the best Is Hodgkin's lymphoma, 60%-70% effective. The efficacy is further enhanced by combination therapy, including combination of immunotherapy and chemotherapy, immunotherapy and targeted therapy.
Linton led a multi-center trial in China, and the combination of rituximab-targeted chemotherapy could improve the efficacy of B-cell lymphoma by 20%, and became the standard treatment for B-cell lymphoma in China. As the first expert to start using PD1/PDL1 for immunotherapy, Professor Lin has not yet seen any cases of drug toxicity deaths, but has repeatedly stressed the need for high attention to the prevention and treatment of immunotherapy toxicity. Linton's team proposed surgical excision combined chemotherapy to treat gastrointestinal junction snoostic NK/T cell lymphoma, which can improve survival rate by 3 times, and become a model for multidisciplinary comprehensive treatment to improve the cure rate.
" is like buying European and American clothes, we Asians will wear too much, the treatment of cancer is the same, the most suitable for individualization, is the most efficient. Lin said that domestic treatment will have a better standard for patient synodic treatment, the right is the best. Many foreign anti-cancer centers are relatively large dose of drugs, from the physical aspects of consideration, not necessarily suitable for Chinese patients.
Lin Yu revealed that the treatment of cancer in China, whether it is drug use or radiotherapy chemotherapy, have developed very rapidly, Beijing, Shanghai, Guangzhou and many other large-scale cancer hospitals, expert team can give patients the most suitable, the most scientific individualized integrated integrated discipline symbiosis joint treatment plan. The 2019 China Cancer Congress also gathered thousands of industry experts, more than 200 top experts in the oncology field speech, together to promote the development of domestic cancer clinical diagnosis and treatment to a new level.
.